Serotonin syndrome from venlafaxine-tranylcypromine interaction

Veterinary and Human Toxicology

Volumn 38, Issue 5, 1996, Pages 358-361

  Brubacher, Jeffrey R ^a   Hoffman, Robert S ^b   Lurin, Matthew J ^b  

^a NEW YORK CITY POISON CONTROL CENTER   (United States)

^b BELLEVUE HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; BROMOCRIPTINE; COCAINE; CREATINE KINASE; DEXTROMETHORPHAN; DIAZEPAM; FLUOXETINE; ISOCARBOXAZID; LEVODOPA; LORAZEPAM; MONOAMINE OXIDASE INHIBITOR; PARGYLINE; PAROXETINE; PETHIDINE; PHENELZINE; PROCARBAZINE; SELEGILINE; SEROTONIN; SEROTONIN 1 ANTAGONIST; SEROTONIN 1A RECEPTOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRANYLCYPROMINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; TRYPTOPHAN; VENLAFAXINE;

ADULT; AGITATION; ARTICLE; CASE REPORT; CLINICAL FEATURE; CONFUSION; DEPRESSION; DIAPHORESIS; HUMAN; HYPERSALIVATION; HYPERTHERMIA; HYPOVENTILATION; INTRAVENOUS DRUG ADMINISTRATION; INTUBATION; MALE; MUSCLE RIGIDITY; MYOCLONUS; NEUROLEPTIC MALIGNANT SYNDROME; ORAL DRUG ADMINISTRATION; PARALYSIS; RHABDOMYOLYSIS; SEDATION; SEROTONIN SYNDROME; SHIVERING; THROMBOCYTOPENIA;

ADULT; ANTIDEPRESSIVE AGENTS; CYCLOHEXANOLS; DIARRHEA; DIAZEPAM; DRUG INTERACTIONS; HUMANS; HYPNOTICS AND SEDATIVES; INTENSIVE CARE UNITS; MALE; RECEPTORS, SEROTONIN; SALIVATION; SEROTONIN UPTAKE INHIBITORS; TRANYLCYPROMINE; TREATMENT OUTCOME; TREMOR;

EID: 0029745403     PISSN: 01456296     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Sternbach H: The serotonin syndrome. Am J Psychiatry 148: 705-713, 1991.
2. Lucki I, Nobler MS, Frazer A: Differential actions of serotonin antagonists on two behavioral models of serotonin receptor activation in the rat. J Pharmacol Exp Ther 228: 133-139, 1984.
3. Costain DW, Green AR: β-Adrenoreceptor antagonists inhibit the behavioural responses of rats to increased brain 5-hydroxytryptamine. Br J Pharmac 64: 193-200, 1978.
4. Vigran IM: Dangerous potentiation of meperidine hydrochloride by pargyline hydrochloride. JAMA 187: 953-954, 1964.
5. Rivers N, Horner B: Possible lethal reaction between nardil and dextromethorphan. Can Med Assoc J 103: 85, 1970.
6. Tordoff SG, Stubbing JF, Linter SPK: Delayed excitatory reaction following interaction of cocaine and monoamine oxidase inhibitor (phenelzine). Br J Anaes 66: 516-528, 1991.
7. Teas GA: Toxic delirium resulting from combination antidepressant therapy. Am J Psychiat 138: 1127, 1981.
8. Skop BP, Finkelstein JA, Mareth TR et al: The serotonin syndrome associated with paroxetine, an over the counter cold remedy, and vascular disease. Am J Emer Med 12: 642-644, 1994.
9. Ambre JA: The urinary excretion of cocaine and metabolites in humans: A kinetic analysis of published data. J Anal Toxicol 9: 241-245, 1985.
10. Setzer SC, Anderson DA, Lawler RJ et al (abstract): Acute venlafaxine overdose - A multicenter study. J Toxicol Clin Toxicol 33: 495, 1995.
11. Personal communications: Wyeth-Ayerst Laboratories drug surveillance. March 1996.
12. Miller F, Friedman R, Tanenbaum J et al: Disseminated intravascular coagulation and acute myoglobinuric renal failure: A consequence of the serotonin syndrome. J Clin Psychopharmacol 11: 277-279, 1991.
13. Yamada J, Sugimoto Y, Horisaka K: The behavioural effects of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) in mice. Europ J Pharmac 154: 299-304, 1988.
14. Lappin RI, Auchincloss EL: Treatment of the serotonin syndrome with cyproheptadine. N Engl J Med 331: 1021-1022, 1994.
15. Sandyk R: L-Dopa induced serotonin syndrome in a parkinsonian patient on bromocryptine. J Clin Psychopharmacol 6: 194-195, 1986.